Molecular imaging has experienced enormous advancements in the areas of imaging
technology, imaging probe and contrast development, and data quality, as well as machine …

Positron emission tomography (PET) has, since its inception, established itself as the
imaging modality of choice for the in vivo quantitative assessment of molecular targets in a …

PET/CT molecular imaging has been imposed in clinical oncological practice over the past
20 years, driven by its two well-grounded foundations: quantification and radiolabeled …

The imaging of specific molecular targets that are associated with cancer should allow
earlier diagnosis and better management of oncology patients. Positron emission …

Radiotherapy and radiation oncology play a key role in the clinical management of patients
suffering from oncological diseases. In clinical routine, anatomic imaging such as contrast …

Positron emission tomography (PET) is a radiotracer imaging method that yields quantitative
images of regional in vivo biology and biochemistry. PET, now used in conjunction with …

OBJECTIVE. This review article explores recent advancements in PET/MRI for clinical
oncologic imaging. CONCLUSION. Radiologists should understand the technical …

Based on the advantages of revealing the functional status and molecular expression of
tumor cells, positron emission tomography (PET) imaging has been performed in numerous …

Positron emission tomography (PET) has emerged as a significant molecular imaging
technique in clinical oncology and cancer research. PET with 18F‐fluorodeoxyglucose (18F …

The diversity in cancer cell characteristics is an area of great interest in the practice of
clinical oncology. By now, we know that tumors can be composed of different …